Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis.
A retrospective study was performed to evaluate the outcome of alendronate (ALN) treatment for seven years in postmenopausal Japanese women with osteoporosis. Forty-seven postmenopausal women with osteoporosis (mean age at baseline 65.7 years) treated with ALN for over seven years in our outpatient clinic were analyzed. Lumbar spine bone mineral density (BMD) was measured using dual energy X-ray absorptiometry, and urinary levels of cross-linked N-terminal telopeptides of type I collagen (NTX) and serum alkaline phosphatase (ALP) were monitored during the seven-year treatment period. Urinary NTX and serum ALP levels decreased (-48.2% at three months and -15.7% at seven years, respectively) and lumbar spine BMD increased (+12.8% at seven years) compared with baseline values. No serious adverse events were observed, including osteonecrosis of jaw, atypical femoral diaphysis fractures, or atrial fibrillation. To our knowledge, this is the first report of the outcome of ALN treatment for seven years in Japanese patients with osteoporosis. ALN successfully suppressed bone turnover and increased lumbar spine BMD from the baseline value over the course of the seven-year treatment period without causing any severe adverse events.
Iwamoto
Jun
J
Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
Sato
Yoshihiro
Y
Uzawa
Mitsuyoshi
M
Takeda
Tsuyoshi
T
Matsumoto
Hideo
H
N Engl J Med. 2008 Mar 20;358(12):1304-6
18354114
J Bone Miner Metab. 2005;23(3):238-42
15838627
Expert Opin Pharmacother. 2009 Oct;10(14):2303-15
19640210
JAMA. 2006 Dec 27;296(24):2927-38
17190893
J Bone Miner Metab. 2004;22(5):462-8
15316867
J Bone Miner Metab. 2005;23(5):382-8
16133688
Ther Clin Risk Manag. 2009;5:773-9
19851524
Osteoporos Int. 1999;10(3):183-92
10525709
Arch Intern Med. 2008 Apr 28;168(8):826-31
18443257
Bone. 2003 Sep;33(3):301-7
13678770
J Bone Miner Metab. 2005;23(2):97-104
15750686
JAMA. 1998 Dec 23-30;280(24):2077-82
9875874
J Bone Miner Res. 2010 May;25(5):976-82
20200926
Clin Ther. 1999 Jun;21(6):1025-44
10440625
J Bone Miner Metab. 2001;19(6):331-7
11685647
Ann Intern Med. 1999 Dec 21;131(12):935-42
10610644
Osteoporos Int. 2009 Aug;20(8):1429-37
19101754
N Engl J Med. 2007 May 3;356(18):1809-22
17476007
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001155
18253985
N Engl J Med. 2004 Mar 18;350(12):1189-99
15028823
Am J Med. 1997 Oct;103(4):291-7
9382121
Lancet. 1996 Dec 7;348(9041):1535-41
8950879
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):2-12
19371809
J Bone Miner Res. 2009 Jul;24(7):1308-13
19257818